ROSA
QUILES PEREZ
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (11)
2021
-
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
Journal of Hepatology, Vol. 75, Núm. 1, pp. 86-97
2020
-
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
Antiviral Research, Vol. 174
2018
-
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry
Clinical Gastroenterology and Hepatology, Vol. 16, Núm. 9, pp. 1495-1502
-
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C
Journal of Hepatology, Vol. 68, Núm. 5, pp. 940-948
2017
-
Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children
PLoS ONE, Vol. 12, Núm. 2
-
The antigenic variability of HCV in viral HLA-Ag binding is related to the activation of the host immune response
Scientific Reports, Vol. 7, Núm. 1
2015
-
Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis
World Journal of Gastroenterology, Vol. 21, Núm. 30, pp. 9163-9174
2012
-
Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer
Molecular Carcinogenesis, Vol. 51, Núm. 8, pp. 608-618
-
Plasma Ribavirin trough concentrations during treatment of chronic hepatitis C in genotype-1 patients
Journal of Clinical Gastroenterology, Vol. 46, Núm. 4, pp. 328-333
2011
-
Hepatic expression of adiponectin receptors increases with non-alcoholic fatty liver disease progression in morbid obesity in correlation with glutathione peroxidase 1
Obesity Surgery, Vol. 21, Núm. 4, pp. 492-500
-
Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin
American Journal of Gastroenterology, Vol. 106, Núm. 7, pp. 1246-1254